Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
-
Catheter Cardiovasc Interv · Jul 2007
Percutaneous rheolytic thrombectomy for large pulmonary embolism: a promising treatment option.
Pulmonary embolism (PE) is a common cardiovascular disease with significant mortality. Some patients with large PE are not eligible for current treatment options such as thrombolysis or surgical embolectomy. We report our experience of percutaneous rheolytic thrombectomy (PRT) using the AngioJet system combined with adjunctive local thrombolytic therapy and inferior vena cava (IVC) filter placement to treat massive or submassive PE in patients ineligible for current treatment options. ⋯ Percutaneous rheolytic thrombectomy using the AngioJet may be a treatment option for patients with massive or submassive PE who may not be eligible for thrombolytic therapy or surgical embolectomy.
-
Catheter Cardiovasc Interv · Jun 2007
Feasibility and clinical impact of transcatheter closure of interatrial communications after a fenestrated Fontan procedure: medium-term outcomes.
This study was to review an institutional experience with transcatheter closure of Fontan fenestrations and its impact on clinical care. ⋯ Transcatheter occlusion of Fontan fenestrations is safe with acute and persistent improvements in oxygen saturations.
-
Catheter Cardiovasc Interv · Jun 2007
Multicenter StudyAccess site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry.
To determine both the etiology of and outcomes associated with access site hematoma requiring transfusion (HRT) in patients undergoing percutaneous coronary intervention (PCI). ⋯ Access site complications, especially HRT, remain a very important predictor of adverse procedural success and patient outcome.